Atai Life Sciences N.V. (ATAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 172 | 37 | 39 | 24 | 170 |
| Gross Profit | 172 | 37 | 39 | 24 | 170 |
| Operating Expenses | 32,034 | 33,251 | 37,604 | 38,447 | 35,527 |
| Operating Income | -31,862 | -33,214 | -37,565 | -38,423 | -35,357 |
| Interest Expense | 658 | 622 | 0 | 0 | 0 |
| Other Income | -1,066 | -353 | -3,082 | 2,857 | -2,101 |
| Pre-tax Income | -33,586 | -34,189 | -40,647 | -35,566 | -37,458 |
| Income Tax | 185 | 165 | 6,002 | 135 | 51 |
| Net Income Continuous | -33,771 | -34,354 | -46,649 | -35,701 | -37,509 |
| Minority Interests | -729 | -1,219 | -1,638 | -1,814 | -891 |
| Net Income | $-33,042 | $-33,135 | $-45,011 | $-33,887 | $-36,618 |
| EPS Basic Total Ops | -0.21 | -0.21 | -0.28 | -0.22 | -0.24 |
| EPS Basic Continuous Ops | -0.22 | -0.22 | -0.29 | -0.23 | -0.24 |
| EPS Diluted Total Ops | -0.21 | -0.21 | -0.28 | -0.22 | -0.24 |
| EPS Diluted Continuous Ops | -0.22 | -0.22 | -0.29 | -0.23 | -0.24 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.21 | -0.28 | -0.22 | N/A |
| EBITDA(a) | $-31,783 | $-33,149 | $-37,512 | $-38,387 | $-35,338 |